Hydroxyapatite vs CPP-ACP, NovaMin, and xylitol

Hydroxyapatite is one of several “remineralising” ideas in modern oral care. It is not the only one—and it is not interchangeable with the others.

This article compares four approaches people often lump together under “remineralising”:

1. Hydroxyapatite (HA) — particulate tooth mineral.
2. CPP-ACP — casein phosphopeptide–amorphous calcium phosphate (Recaldent; MI Paste / Tooth Mousse families).
3. NovaMin — calcium sodium phosphosilicate bioactive glass.
4. Xylitol — a sugar alcohol used as a sweetener and caries adjunct.

They share shelf space and marketing vocabulary. They do not share one mechanism.

Fluoride remains the best-evidenced anticaries toothpaste active overall; this page is about how the non-fluoride or adjunct options differ from each other. For the fluoride head-to-head, see hydroxyapatite vs fluoride.

Shared goal, different chemistry

All four are marketed around enamel health, early lesions, sensitivity, or caries risk. Only HA and NovaMin deposit mineral-like material on the tooth in a fairly direct sense. CPP-ACP mainly stabilises and delivers calcium and phosphate ions. Xylitol mainly changes the bacterial / salivary environment.

Understanding that split prevents false comparisons—like asking whether xylitol “remineralises like HA.”

A quick map before the deep dive

None of these erase fluoride’s lead for population-level caries prevention. They answer different product and clinical niches.

Hydroxyapatite — particulate biomimetic mineral

What it is: Synthetic Ca₁₀(PO₄)₆(OH)₂ particles (nano, micro, or blends), sometimes carbonate- or zinc-substituted.

How it is proposed to work:

• Direct deposition / adhesion onto enamel.
• Release of Ca²⁺ and PO₄³⁻ that support local supersaturation.
• Occlusion of open dentinal tubules (sensitivity).
• Reduced bacterial adhesion in short in-situ work.

Evidence shape: Stronger laboratory and in-situ remineralisation map; clinical non-inferiority caries RCTs for specific 10% pastes; comparatively robust sensitivity meta-analyses. Many clinical papers are industry-funded.

Honest limits: HA has not been shown to outperform fluoride for caries. Non-inferiority within generous margins is not equivalence at public-health scale. Particle grades differ; do not cite a microcrystalline trial as proof of a nano product’s superiority.

For concentration questions (5% vs 10%), see how much hydroxyapatite you need.

CPP-ACP — milk-derived calcium phosphate carrier

What it is: Casein phosphopeptides (from milk protein) stabilising amorphous calcium phosphate so calcium and phosphate stay bioavailable instead of precipitating too quickly. Commercialised as Recaldent™. Consumer products include GC Tooth Mousse / MI Paste; versions with fluoride are often labelled CPP-ACPF / MI Paste Plus.

How it is proposed to work:

• CPP-ACP binds to plaque, pellicle, and tooth surfaces.
• When pH falls, the complex releases calcium and phosphate, helping maintain supersaturation.
• With fluoride, it can support fluorapatite-related repair pathways.

Evidence shape: Substantial in-vitro and clinical literature on early lesions and white-spot appearance, including systematic reviews/meta-analyses reporting improvement versus baseline on some imaging endpoints (for example QLF-based analyses in Ma et al., 2019). Results versus strong fluoride regimens are mixed; CPP-ACP is often positioned as an adjunct, especially in orthodontic white-spot care, rather than a full toothpaste replacement for fluoride.

Practical caveats:

• Milk-protein origin means it is generally unsuitable for people with milk protein allergy (lactose intolerance is a different issue—check product guidance).
• Many CPP-ACP products are crémes used after brushing, not a 1:1 swap for your daily dentifrice.
• “Plus” versions with fluoride are not fluoride-free options.

NovaMin — bioactive glass that forms an apatite-like layer

What it is: Calcium sodium phosphosilicate (CSPS), a bioactive glass trademarked as NovaMin. Familiar to many people via Sensodyne Repair & Protect–type formulas, which typically combine NovaMin with fluoride.

How it is proposed to work:

• On contact with saliva/water, sodium exchanges and local pH rises transiently.
• Calcium and phosphate are released; a calcium-phosphate layer forms and crystallises toward hydroxycarbonate apatite.
• That layer can occlude dentinal tubules, supporting sensitivity relief.
• Remineralisation claims are mechanism-linked; clinical superiority over conventional fluoride toothpaste for white-spot / caries endpoints is not consistently shown.

Evidence shape: Multiple clinical studies support hypersensitivity reduction. Manufacturer-facing summaries describe numerous randomised sensitivity trials across large pooled participant counts; independent systematic reviews of remineralisation specifically have been more cautious. Remineralisation evidence is mixed: in-vitro signals exist; some orthodontic white-spot trials do not show clear superiority over fluoride controls; reviews have called for better trials before strong remineralisation recommendations.

Hoffman et al. (2015), for example, randomised orthodontic patients to a NovaMin + high-fluoride paste versus a conventional fluoride control and did not find a lasting significant advantage for white-spot outcomes at the final time point summarised in later reviews.

Practical caveat: If your goal is a fluoride-free routine, check the full INCI/active list. Many NovaMin retail pastes are not fluoride-free.

Xylitol — not a remineralising mineral

What it is: A five-carbon sugar alcohol used to sweeten gum, pastes, and syrups.

How it is proposed to work:

• Less fermentable than sucrose for many cariogenic bacteria.
• Can reduce Streptococcus mutans challenge with sufficient dose/frequency in some study designs.
• Stimulates saliva, which itself carries calcium and phosphate.

What it is not: A calcium-phosphate donor. Calling xylitol a “remineraliser” stretches the term. Any enamel benefit is mostly indirect.

Evidence shape: The 2015 Cochrane review (Riley et al.) found low-quality evidence that fluoride toothpaste containing 10% xylitol may reduce caries by about 13% over 2.5–3 years versus fluoride-only toothpaste in children’s permanent teeth—based on two studies from the same research group/population, with high risk of bias concerns. Evidence for other xylitol formats (gums, syrups, etc.) was insufficient or very low certainty for broad conclusions.

Many HA pastes include xylitol as a supporting ingredient. That is common formulation practice, not proof of synergy from a dedicated factorial trial.

Practical caveats: High doses of xylitol can cause gastrointestinal upset. Dogs should never be given xylitol-containing products—toxicity risk is serious for pets, even when human oral-care use is routine.

Xylitol also illustrates a broader labelling problem: co-ingredients get marketed as if they were the primary remineralising system. In an HA paste, xylitol is usually a supporting sweetener with possible adjunctive anti-caries rationale—not the reason the paste belongs in the “remineralising mineral” bucket.

Side-by-side comparison

Where each tends to fit

If your main issue is sensitivity

HA and NovaMin both have coherent tubule-occlusion stories and clinical sensitivity data. Potassium nitrate pastes (not covered in depth here) use a nerve-desensitising route instead. Choice often comes down to whether you want a fluoride-containing NovaMin paste or a fluoride-free HA paste—and what your dentist prefers for your caries risk.

Limeback et al. (2023) meta-analysis figures for HA versus placebo and versus fluoride are summarised in our sensitivity article. NovaMin’s commercial literature emphasises occlusion and hydroxycarbonate apatite layer formation; many retail SKUs keep fluoride in the formula, so they are not clean “fluoride-free alternative” picks.

If your main issue is early white spots after braces

CPP-ACP crémes are frequently used as adjuncts alongside fluoride hygiene. HA and fluoride toothpastes also appear in white-spot / in-situ remineralisation research. None of these replace professional assessment of lesions that may need resin infiltration or restorative care.

Orthodontic white spots are a high-visibility problem with mixed product evidence. Expect adjunctive care plus hygiene coaching more often than a single hero ingredient.

If your main issue is cavity prevention

Fluoride still has the largest evidence base. Among the options on this page, HA has the clearest modern toothpaste non-inferiority caries RCTs; xylitol’s toothpaste signal is low-certainty and adjunctive; CPP-ACP and NovaMin are better framed as mineral-support or sensitivity technologies than as fluoride replacements.

If someone tells you NovaMin or CPP-ACP “replaced fluoride,” ask for the caries RCT that shows it. For HA, the honest citation is non-inferiority—not replacement of the scientific consensus.

If acid wear is the concern

Mechanistic stories differ—HA’s “sacrificial layer,” CPP-ACP’s ion reservoir, NovaMin’s surface precipitate—but long-duration clinical erosion trials are limited across the board. Lifestyle timing (don’t brush immediately after acid) usually matters more than ingredient branding. See hydroxyapatite and enamel erosion.

If milk allergy or vegan preference matters

CPP-ACP is milk-protein-derived. HA, NovaMin, and xylitol do not carry that specific constraint (always check full formulas for other animal-derived additives). This is one of the clearest non-efficacy reasons to choose HA over CPP-ACP.

Evidence quality, side by side (without a fake ranking)

It is tempting to declare a single winner among HA, CPP-ACP, NovaMin, and xylitol. That usually means collapsing different endpoints into one score.

A fairer scorecard:

For dentin hypersensitivity: HA and NovaMin both have clinical support via occlusion mechanisms. Head-to-head “always better” claims between the two are not settled for every formula.

For early white-spot appearance / mineral metrics: CPP-ACP has a large specialised literature as an adjunct; HA and fluoride dentifrices also appear in in-situ remineralisation work. Imaging improvements are not the same as cavity prevention.

For toothpaste caries endpoints versus fluoride: HA currently has the clearest modern non-inferiority RCT set among fluoride-free daily pastes discussed here. Those trials remain few, often industry-funded, and non-inferiority by design.

For adjunctive caries risk reduction in fluoride toothpaste: xylitol has a low-certainty Cochrane signal at 10% in fluoride paste—not a remineralisation story and not a licence to drop fluoride.

For replacing fluoride as public-health default: none of the four.

Reading industry and academic papers together

CPP-ACP research has deep academic roots (notably University of Melbourne / Recaldent development). NovaMin research is intertwined with consumer oral-care companies commercialising bioactive glass. HA caries RCTs often involve manufacturer funding (Dr. Kurt Wolff; historically Sangi). Xylitol trials vary widely in quality.

Industry involvement is common in oral-care ingredients. The fix is disclosure and design scrutiny—not pretending only one camp has conflicts.

Sometimes, yes:

• HA toothpaste + xylitol is already common in one tube.
• Fluoride toothpaste + CPP-ACP crème is a familiar clinical adjunct pattern.
• NovaMin pastes often already include fluoride.

Stacking everything at once is not automatically better. More actives mean more cost, more allergy/tolerance variables, and more marketing noise without a clear hierarchy of benefit.

A worked example

Someone with orthodontic white spots and mild sensitivity might reasonably use:

1. A fluoride toothpaste (or dentist-directed high-fluoride paste) as the caries backbone.
2. A CPP-ACP crème as a timed adjunct on affected surfaces.
3. An occluding paste (HA or NovaMin) if sensitivity is bothersome—checking whether the sensitivity paste already contains fluoride so they are not accidentally double-counting or abandoning fluoride without noticing.

That is a clinician-style stack. A consumer who instead buys four “remineralising” products from social media without a diagnosis is more likely to spend money than to outrun disease risk.

What “most trials” actually means here

FAQ-style comparisons often ask which remineraliser has the most trials. The accurate answer still starts with fluoride. Among the four options on this page:

• HA: fewer caries RCTs, but modern toothpaste non-inferiority designs exist.
• CPP-ACP: many white-spot / remineralisation studies across formats; toothpaste-replacement claims are weaker.
• NovaMin: many sensitivity studies; remineralisation superiority less consistent.
• Xylitol: mixed low-certainty caries evidence as an adjunct, especially with fluoride toothpaste.

Quantity of papers is not quality. A dozen small, heterogeneous white-spot studies do not automatically beat three carefully reported non-inferiority RCTs—or vice versa—without looking at endpoints.

Bottom line

Hydroxyapatite is a particulate mineral approach with growing clinical data. CPP-ACP is a milk-derived calcium-phosphate delivery system often used as an adjunct. NovaMin is a bioactive glass best known clinically for sensitivity formulas (frequently with fluoride). Xylitol is not a remineralising mineral at all.

None of them erase fluoride’s evidence lead for caries prevention. Use them as distinct tools—not as synonyms—and match the tool to the job you actually need done.